Preventing HIV Infection among Injecting Drug Users in High Risk Countries: An Assessment of the Evidence

Questions? Call 800-624-6242

About | Ordering | New

LoginRegister

| Items in cart [0]

PAPERBACK
price:$61.25
add to cart

Rights & Permissions

Free PDF Access

Free Resources

Related Titles

Preventing HIV Infection among Injecting Drug Users in High Risk Countries: An Assessment of the Evidence (2006)
Board on Global Health (BGH)

Citation Manager Export the bibliographic data for this book in your chosen format
Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web.
Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book.
Reference Finder Paste in your own text to find books that relate to your topic.

Citation Manager

. "Summary." Preventing HIV Infection among Injecting Drug Users in High Risk Countries: An Assessment of the Evidence. Washington, DC: The National Academies Press, 2006.

Please select a format:

Page
26


E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.

Vanichseni S, Wongsuwan B, Choopanya K, Wongpanich K. 1991. A controlled trial of methadone maintenance in a population of intravenous drug users in Bangkok: Implications for prevention of HIV. The International Journal of Addictions. 26(12):1313– 1320.

Washton AM, Pottash AC, Gold MS. 1984. Naltrexone in addicted business executives and physicians. Journal of Clinical Psychiatry. 45(9 pt 2):39–41.

WHO (World Health Organization). 2004a. Evidence for Action: Effectiveness of Community-Based Outreach in Preventing HIV/AIDS Among Injecting Drug Users. Geneva, Switzerland: WHO.

WHO. 2004b. Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants: Guidelines on Care, Treatment and Support for Women Living with Hiv/Aids and Their Children in Resource-Constrained Settings. Geneva, Switzerland: WHO.

WHO. 2005a. Evidence for Action: Effectiveness of Drug Dependence Treatment in Preventing HIV Among Injecting Drug Users. Geneva, Switzerland: WHO.

WHO. 2005b. Policy and Programming Guide for HIV/AIDS Prevention and Care Among Injecting Drug Users. Geneva, Switzerland: WHO.

WHO. 2005c. WHO Model List of Essential Medicine. 14th edition. [Online]. Available: http://whqlibdoc.who.int/hq/2005/a87017_eng.pdf [accessed August 11, 2006].

WHO, UNODC, UNAIDS. 2004. Substitution Maintenance Therapy in the Management of Opioid Dependence and HIV/AIDS Prevention: Position Paper. Geneva, Switzerland: WHO.

Wiebel WW, Jimenez A, Johnson W, Ouellet L, Jovanovic B, Lampinen T, Murray J, O’Brien MU. 1996. Risk behavior and HIV seroincidence among out-of-treatment injection drug users: A four-year prospective study. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 12(3):282–289.

Williams AB, McNelly EA, Williams AE, D’Aquila RT. 1992. Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users. AIDS Care. 4(1): 35–41.